Key Takeaways
- • Unconventional Ventures announced the second close of Fund II in April 2026, building on a €50 million first close achieved in November 2025, with a total target of €80 million ($94 million USD).
- • The Nordic impact venture capital firm, led by general partners Nora Bavey and Thea Messel, focuses exclusively on pre-seed and seed-stage companies founded by women and founders of color addressing climate, health, education, and financial inclusion.
- • New limited partners Wire Group and Merete Lundbye Møller joined returning investor Investinor at the second close, signaling sustained institutional confidence in the fund's thesis around underrepresented founder demographics.
- • Historical funding gaps drive the fund's investment thesis: all-women founding teams receive 1–2% of venture capital, while founders-of-color-led startups receive less than 0.5%.
- • Portfolio companies span climate fintech (Climate X), edtech (Scifree, Sweden), biotech (Cellugy, Denmark), and femtech (The Blue Box), reflecting the fund's sector diversification within impact technology.
Summary
Unconventional Ventures, a Copenhagen-based impact venture capital firm, announced the second close of its Fund II in April 2026, advancing its capital raise toward a €80 million target. The firm had closed €50 million at its first close in November 2025, representing 62.5% of the target. The second close brought new institutional commitment from Wire Group and Merete Lundbye Møller alongside continued support from existing investor Investinor, according to a LinkedIn announcement by general partner Nora Bavey.
Founded by general partners Nora Bavey and Thea Messel, Unconventional Ventures was established to address systemic capital allocation biases in venture investing. The firm focuses exclusively on early-stage companies—pre-seed and seed rounds—led by women founders and founders of color building scalable technology with measurable environmental or social impact. The investment thesis is grounded in quantifiable funding disparities: all-women founding teams historically receive just 1% to 2% of venture capital globally, while startups led by founders of color capture less than 0.5% of total venture funding.
The fund's geographic focus is restricted to The Nordics and Europe, with sector concentration in climate and environment, health and femtech, education, and financial inclusion. Portfolio companies demonstrate this thematic alignment: Climate X operates as a climate fintech platform; Scifree provides edtech solutions from Sweden; Cellugy develops biotech innovations from Denmark; and The Blue Box serves the femtech sector. This portfolio composition reflects both the firm's impact mandate and its strategic positioning within high-growth technology segments.
Bavey's statement accompanying the second close emphasized that the milestone would enable team expansion and operational strengthening to better support the firm's founder cohort. This narrative aligns with typical venture fund development cycles, where capital progression between closes often funds increased operational capacity and portfolio support infrastructure rather than purely additional deployable capital.
Founded by general partners Nora Bavey and Thea Messel, Unconventional Ventures was established to address systemic capital allocation biases in venture investing. The firm focuses exclusively on early-stage companies—pre-seed and seed rounds—led by women founders and founders of color building scalable technology with measurable environmental or social impact. The investment thesis is grounded in quantifiable funding disparities: all-women founding teams historically receive just 1% to 2% of venture capital globally, while startups led by founders of color capture less than 0.5% of total venture funding.
The fund's geographic focus is restricted to The Nordics and Europe, with sector concentration in climate and environment, health and femtech, education, and financial inclusion. Portfolio companies demonstrate this thematic alignment: Climate X operates as a climate fintech platform; Scifree provides edtech solutions from Sweden; Cellugy develops biotech innovations from Denmark; and The Blue Box serves the femtech sector. This portfolio composition reflects both the firm's impact mandate and its strategic positioning within high-growth technology segments.
Bavey's statement accompanying the second close emphasized that the milestone would enable team expansion and operational strengthening to better support the firm's founder cohort. This narrative aligns with typical venture fund development cycles, where capital progression between closes often funds increased operational capacity and portfolio support infrastructure rather than purely additional deployable capital.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.